Pernix Therapeutics revenue

Pernix Therapeutics revenue increased from $140.9 million in 2016 to $146.1 million in 2017, a 3.7% increase.

Annual Revenue ($)

Pernix Therapeutics revenue was $146.07 m in FY, 2017

Quarterly Revenue ($)

FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017
Revenue$60.61 m$61.31 m$84.87 m$121.75 m$175.85 m$140.86 m$146.07 m
Growth43.45%44.44%
Q2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018
Revenue$12.04 m$17.06 m$14.48 m$10.50 k$18.13 k$22.08 b$20.57 m$18.30 m$19.05 m$17.38 m$31.48 m$33.89 m$46.98 m$48.62 m$32.47 m$36.75 m$41.47 m$29.74 m$34.32 m$40.47 m$28.14 m$21.09 m$37.16 m

Annual Growth Rate (%)